Total Compensation FY2025
$4.5M
As reported in 2026 DEF 14A proxy filing with the SEC
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Compensation Breakdown
Base Salary
$1.7M
38% of total
Stock Awards
—
0% of total
Bonus
—
0% of total
Other Compensation
—
0% of total
Compensation History
Total compensation by fiscal year, as reported in SEC proxy filings.
About David Ricks
David Ricks has served as Eli Lilly's CEO since 2017, overseeing the company's blockbuster weight loss and diabetes drug pipeline.
Data Source: Compensation figures are sourced from Eli Lilly's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission (SEC) via EDGAR. Figures reflect total compensation for FY2025 as reported in the Summary Compensation Table. See something wrong? Report it.